ReviewDiabetes2013

An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes.

Jonathan E Noonan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.